Month: August 2020

Raison sociale de l’émetteur : Crédit Agricole S.A. – SA au capital de 8 654 066 136 eurosImmatriculée sous le n°   790 608 416 R.C.S. NANTERRESiège social :   MONTROUGE (92120) 12, place des États-Unis

Digital Displays to Feature End-to-End Solutions for 5G, AI and System-level TestTOKYO, Aug. 06, 2020 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will participate in the first virtual SEMICON Southeast Asia (SEMICON SEA) on August 11-21 as a sponsor, exhibiting its latest end-to-end IC test solutions and presenting a technical paper.Advantest is committed to adding value within the electronics supply chain and to maintaining connections with customers, despite COVID-19’s impact on industry trade shows and conferences. Having successfully participated in the first virtual SEMICON West on July 20-23, virtual SEMICON SEA offers another opportunity for Advantest to demonstrate its industry leadership by leveraging the digital event environment to share information about its latest...

NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) — In a release issued on Wednesday, August 5th, by Weyland, Tech. (OTCQX: WEYL), the text in the headline and body have been corrected. The corrected release follows:Weyland Tech’s AtozGo Launch Co-Marketing Campaign for Food Delivery Service in Jakarta with ShopeePayWeyland Tech, Inc. (OTCQX: WEYL), a leading global provider of eCommerce, mCommerce, and fintech business enablement solutions, has partnered with ShopeePay, Indonesia’s integrated e-money services, to launch a marketing campaign for Weyland’s fast-growing AtozGo™ food delivery service in Jakarta.As recently announced, the partnership between AtozGo and ShopeePay will allow AtozGo users to transact in-app using ShopeePay. Through this integration, AtozGo will benefit from hundreds of thousands of merchants and millions of users...

Šiaulių Bankas AB (hereinafter referred to as the Bank), company code 112025254, domicile address Tilžės st. 149, Šiauliai, Lithuania.During the Investor Conference Webinar Vytautas Sinius, CEO and Donatas Savickas, CFO introduced the Bank’s financial results for the first half of the year 2020 and answered the participant questions aftewards.The live coverage was followed by more than 40 participants, recording of the investor webinar (in English) is available there.Presentation of the webinar (in English): https://sb.lt/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdf?token=/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdfŠiaulių Bankas thanks all participants.Additional information:Tomas VarenbergasHead of Treasury and Marketstomas.varenbergas@sb.lt, +370 5 203 22 00

AB Šiaulių bankas (toliau – Bankas), įmonės kodas 112025254, buveinės adresas: Tilžės g. 149, Šiauliai, Lietuva.Internetiniame seminare Banko administracijos vadovas Vytautas Sinius bei Finansų ir rizikos valdymo tarnybos vadovas Donatas Savickas komentavo Banko 2020 metų pirmojo pusmečio finansinius veiklos rezultatus bei aktualijas ir po pristatymo atsakė į dalyvių klausimus.Seminarą sekė daugiau kaip 40 dalyvių, internetinio seminaro įrašą (anglų kalba) galima rasti čiaPristatymas (anglų kalba): https://sb.lt/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdf?token=/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdfBankas dėkoja seminaro dalyviams.Papildoma informacija:Tomas VarenbergasRinkų ir iždo departamento direktoriustomas.varenbergas@sb.lt, +370 5 203 22 00

                                                                                                                                                 Second quarter in briefDr Elaine Sullivan, Dr Aleksandar Danilovski and Dr Axel Glasmacher were appointed as new members of the Board at the Annual General Meeting on May 19Active Biotech provided status update in the portfolio projectsNew preclinical data on tasquinimod’s effects in experimental models for multiple myeloma were presented at the Virtual Edition of the 25th European Hematology Association Annual Congress Meeting in June                   Events after the end of the period            ·First patient dosed in the phase 1b/2a study of tasquinimod use in treatment of multiple myelomaFinancial summaryFor further information, please contact:The report is also available at www.activebiotech.com.This...

                                                                                                                                                  Kvartal 2 i korthetDr Elaine Sullivan, Dr Aleksandar Danilovski och Dr Axel Glasmacher, utsågs till nya styrelseledamöter vid årsstämman den 19 majActive Biotech tillhandahöll statusuppdatering i portföljprojektenNya prekliniska data med tasquinimod i experimentella modeller för multipel myelom presenterades på den virtuella versionen av 25th European Hematology Association Annual Congress Meeting i juniHändelser efter periodens utgång            ·Första patienten har doserats i fas 1b/2a-studien med tasquinimod vid behandling av multipelt myelomEkonomisk översiktFör ytterligare information, vänligen kontakta:Rapporten finns även tillgänglig på www.activebiotech.com.Denna information är sådan...

In the second quarter (1 April – 30 June) of the 2020 financial year, Tallink Grupp AS and its subsidiaries (the Group) carried 388 thousand passengers, which is 85.4% less than in the second quarter last year. The number of cargo units transported decreased by 12.8% in the same comparison. The Group’s unaudited consolidated revenue decreased by 74.6% or EUR 191.1 million to a total of EUR 65.0 million. Unaudited EBITDA was EUR 2.4 million (EUR 50.7 million in Q2 2019) and unaudited net loss was EUR 27.4 million (net profit of EUR 14.9 million in Q2 2019).In the second quarter, the Group’s revenue and operating results were impacted by the following operational factors:Covid-19 and related travel restrictions.978 trips less due to suspended operations.Restrictions on maximum capacity.Impact of Covid-19 and travel restrictionsDue to the...

Tallink Grupp AS ja tema tütarettevõtted (edaspidi “kontsern“) vedas 2020. aasta teises kvartalis 388 tuhat reisijat, mida on 85,4% võrra vähem kui eelmise aasta teises kvartalis. Veetud kaubaveoühikute arv langes eelmise aastaga võrreldes 12,8% võrra. Kontserni auditeerimata müügitulu langes 74,6% ehk 191,1 miljoni euro võrra 65,0 miljoni euroni. Auditeerimata kulumieelne ärikasum (EBITDA) oli 2,4 miljonit eurot (2019. aasta teises kvartalis 50,7 miljonit eurot) ja auditeerimata puhaskahjum 27,4 miljonit eurot (2019. aasta teise kvartali puhaskasum oli 14,9 miljonit eurot).Teises kvartalis mõjutasid kontserni müügitulu ja majandustulemust järgmised äritegevusega seotud tegurid:Covid-19 ja sellega seotud reisipiirangud;tegevuse ajutise peatamise tõttu 978 võrra vähenenud reiside arv;maksimaalset täituvust sätestavad piirangud.Koroonaviiruse...

GENEVA, Aug. 06, 2020 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), an  independent renewable power producer, released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and six months ended June 30, 2020.Etrion delivered steady project-level results in the second quarter of 2020 from its Japanese assets. The optimization of the Japanese corporate structure and renegotiation of the operations and maintenance (“O&M”) contracts partially offset the impact of lower solar irradiation levels compared to the same period in 2019.Q2-20 HIGHLIGHTSOperationalEtrion produced 20.5 Gigawatt-hours (“GWh”) of electricity from the Company’s 57-megawatt (“MW”) portfolio comprising 11 solar power plant sites in Japan....